Home

insegnare costola Costrizione gene expression correlates of clinical prostate cancer behavior Esenzione Ballerino Perversione

Prognostic values of the core components of the mammalian circadian clock  in prostate cancer [PeerJ]
Prognostic values of the core components of the mammalian circadian clock in prostate cancer [PeerJ]

Identification of potential therapeutic targets in prostate cancer through  a cross‐species approach | EMBO Molecular Medicine
Identification of potential therapeutic targets in prostate cancer through a cross‐species approach | EMBO Molecular Medicine

Increased nuclear factor I/B expression in prostate cancer correlates with  AR expression | bioRxiv
Increased nuclear factor I/B expression in prostate cancer correlates with AR expression | bioRxiv

Differential Expression of Glucose Transporters and Hexokinases in Prostate  Cancer with a Neuroendocrine Gene Signature: A Mechanistic Perspective for  18F-FDG Imaging of PSMA-Suppressed Tumors | Journal of Nuclear Medicine
Differential Expression of Glucose Transporters and Hexokinases in Prostate Cancer with a Neuroendocrine Gene Signature: A Mechanistic Perspective for 18F-FDG Imaging of PSMA-Suppressed Tumors | Journal of Nuclear Medicine

Dysregulation of the splicing machinery is directly associated to  aggressiveness of prostate cancer - eBioMedicine
Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer - eBioMedicine

Increased KIF4A expression is a potential prognostic factor in prostate  cancer - Document - Gale Academic OneFile
Increased KIF4A expression is a potential prognostic factor in prostate cancer - Document - Gale Academic OneFile

A novel gene expression test method of minimizing breast cancer risk in  reduced cost and time by improving SVM-RFE gene selection method combined  with LASSO
A novel gene expression test method of minimizing breast cancer risk in reduced cost and time by improving SVM-RFE gene selection method combined with LASSO

BioMedInformatics | Free Full-Text | BDP1 Expression Correlates with  Clinical Outcomes in Activated B-Cell Diffuse Large B-Cell Lymphoma | HTML
BioMedInformatics | Free Full-Text | BDP1 Expression Correlates with Clinical Outcomes in Activated B-Cell Diffuse Large B-Cell Lymphoma | HTML

Dynamic prostate cancer transcriptome analysis delineates the trajectory to  disease progression | Nature Communications
Dynamic prostate cancer transcriptome analysis delineates the trajectory to disease progression | Nature Communications

miR‑769‑5p is associated with prostate cancer recurrence and modulates  proliferation and apoptosis of cancer cells
miR‑769‑5p is associated with prostate cancer recurrence and modulates proliferation and apoptosis of cancer cells

Gene expression correlates of clinical prostate cancer behavior -  ScienceDirect
Gene expression correlates of clinical prostate cancer behavior - ScienceDirect

A prognostic model of non small cell lung cancer based on TCGA and ImmPort  databases | Scientific Reports
A prognostic model of non small cell lung cancer based on TCGA and ImmPort databases | Scientific Reports

Gene expression arrays in cancer research: methods and applications - ppt  download
Gene expression arrays in cancer research: methods and applications - ppt download

Expression and ERG regulation of PIM kinases in prostate cancer - Eerola -  2021 - Cancer Medicine - Wiley Online Library
Expression and ERG regulation of PIM kinases in prostate cancer - Eerola - 2021 - Cancer Medicine - Wiley Online Library

Androgen receptor profiling predicts prostate cancer outcome | EMBO  Molecular Medicine
Androgen receptor profiling predicts prostate cancer outcome | EMBO Molecular Medicine

MELK expression correlates with tumor mitotic activity but is not required  for cancer growth | eLife
MELK expression correlates with tumor mitotic activity but is not required for cancer growth | eLife

The heterogeneity of prostate cancers lacking AR activity will require  diverse treatment approaches in: Endocrine-Related Cancer Volume 28 Issue 8  (2021)
The heterogeneity of prostate cancers lacking AR activity will require diverse treatment approaches in: Endocrine-Related Cancer Volume 28 Issue 8 (2021)

Genomic correlates of clinical outcome in advanced prostate cancer | PNAS
Genomic correlates of clinical outcome in advanced prostate cancer | PNAS

PDF) Gene expression correlates of clinical prostate cancer behavior |  Dinesh Kumar - Academia.edu
PDF) Gene expression correlates of clinical prostate cancer behavior | Dinesh Kumar - Academia.edu

Module Analysis Captures Pancancer Genetically and Epigenetically  Deregulated Cancer Driver Genes for Smoking and Antiviral Response -  eBioMedicine
Module Analysis Captures Pancancer Genetically and Epigenetically Deregulated Cancer Driver Genes for Smoking and Antiviral Response - eBioMedicine

Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A  enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate  cancer | Oncogene
Targeting the glucocorticoid receptor signature gene Mono Amine Oxidase-A enhances the efficacy of chemo- and anti-androgen therapy in advanced prostate cancer | Oncogene

A TMEFF2-regulated cell cycle derived gene signature is prognostic of  recurrence risk in prostate cancer | BMC Cancer | Full Text
A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer | BMC Cancer | Full Text

Gene Expression Correlates of Clinical Prostate Cancer Behavior | Request  PDF
Gene Expression Correlates of Clinical Prostate Cancer Behavior | Request PDF

Anti-CCR4 treatment depletes regulatory T cells and leads to clinical  activity in a canine model of advanced prostate cancer | Journal for  ImmunoTherapy of Cancer
Anti-CCR4 treatment depletes regulatory T cells and leads to clinical activity in a canine model of advanced prostate cancer | Journal for ImmunoTherapy of Cancer